B. Godbert
Impact in
- Hepatology top 5%
- Liver physiology and pathology
-
- Lung Cancer Treatments and Mutations
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis
Papers in ⓘ
-
- Lung Cancer Diagnosis and Treatment 6
- Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis 4
- Lung Cancer Treatments and Mutations 4
- Pleural and Pulmonary Diseases 2
-
- Mycobacterium research and diagnosis 2
- Co-authors
- Marie-Pierre Wissler (1 shared paper)Jean-Michel Vignaud (1 shared paper)Jerome H. Goldschmidt (1 shared paper)Taral Patel (1 shared paper)Robert L. Yauch (1 shared paper)S. Phan (1 shared paper)G. Robinet (1 shared paper)Ramaswamy Govindan (1 shared paper)
In The Last Decade
B. Godbert
16 papers receiving 536 citations
Hit Papers
Peers
Comparison fields: 5 of 66
- Hepatology 151
- Pulmonary and Respiratory Medicine 325
- Oncology 207
- Cancer Research 65
- Pathology and Forensic Medicine 57
Countries citing papers authored by B. Godbert
This map shows the geographic impact of B. Godbert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B. Godbert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B. Godbert more than expected).
Fields of papers citing papers by B. Godbert
This network shows the impact of papers produced by B. Godbert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B. Godbert. The network helps show where B. Godbert may publish in the future.
Co-authors
The 25 scholars most cited alongside B. Godbert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Randomized Phase II Trial of Onartuzumab in Combination With Erlotinib in Patients With Advanced Non–Small-Cell Lung Cancer Hit paper breakdown → | 2013 | 370 |
| 2 | 2013 | 60 | |
| 3 | 2014 | 54 | |
| 4 | 2020 | 20 | |
| 5 | 2020 | 18 | |
| 6 | 2021 | 7 | |
| 7 | Radiation Recall Pneumonitis in A PatientTreated by Nivolumab for Non-Small CellLung Cancer, No Relapse with Rechallenge | 2018 | 7 |
| 8 | 2011 | 4 | |
| 9 | 2010 | 3 | |
| 10 | 2013 | 2 | |
| 11 | 2012 | 2 | |
| 12 | 2016 | 1 | |
| 13 | 2024 | 1 | |
| 14 | 2021 | 1 | |
| 15 | 2023 | 1 | |
| 16 | 2015 | 1 | |
| 17 | 2025 | 0 | |
| 18 | 2024 | 0 | |
| 19 | 2023 | 0 |
About B. Godbert
B. Godbert is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology, Surgery, Oncology and Hepatology, having authored 19 papers that have together received 552 indexed citations. Recurring topics across this work include Lung Cancer Diagnosis and Treatment (6 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers), Lung Cancer Treatments and Mutations (4 papers), Hepatocellular Carcinoma Treatment and Prognosis (3 papers), Pleural and Pulmonary Diseases (2 papers), Tuberculosis Research and Epidemiology (2 papers), Infectious Diseases and Tuberculosis (2 papers) and Mycobacterium research and diagnosis (2 papers). The work is most often cited by research in Hepatology (151 citations), Pulmonary and Respiratory Medicine (325 citations), Oncology (207 citations), Cancer Research (65 citations) and Pathology and Forensic Medicine (57 citations). B. Godbert has collaborated with scholars based in France, Belgium and China. Frequent co-authors include Marie-Pierre Wissler, Jean-Michel Vignaud, Jerome H. Goldschmidt, Taral Patel, Robert L. Yauch, S. Phan, G. Robinet, Ramaswamy Govindan, Davey B. Daniel and David R. Spigel. Their work appears in journals such as Journal of Clinical Oncology, Clinical Microbiology and Infection, Journal of Thoracic Oncology, European Journal of Internal Medicine and Interactive Cardiovascular and Thoracic Surgery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.